Despite concerns that the administration might meddle with a committee of vaccine advisers to the Centers for Disease Control and Prevention, their first public meeting since President Trump's inauguration followed its usual course.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,